FDA Approved: SODIUM PHENYLACETATE AND SODIUM BENZOATE — Original Application (MAIA PHARMACEUTICALS, INC)

View source ↗

Summary

FDA approved an original application for the generic combination product sodium phenylacetate and sodium benzoate for the treatment of hyperammonemia associated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• Urea Cycle Disorders

Drugs mentioned

• Sodium phenylacetate and sodium benzoate (sodium phenylacetate and sodium benzoate)

Snippet

ORIG AP for SODIUM PHENYLACETATE AND SODIUM BENZOATE (SODIUM PHENYLACETATE AND SODIUM BENZOATE)